These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 33777811)
1. SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC. Peng X; Chen R; Cai S; Lu S; Zhang Y Front Oncol; 2021; 11():650355. PubMed ID: 33777811 [TBL] [Abstract][Full Text] [Related]
2. NABP2 as an oncogenic biomarker promotes hepatocellular carcinoma progression and metastasis. Peng H; Cai S; Chen R; Tan L; Lu S; Lu X; Hang Y; Zhang Y; Peng X Am J Transl Res; 2023; 15(6):4203-4227. PubMed ID: 37434816 [TBL] [Abstract][Full Text] [Related]
3. Centromere Protein F ( Huang Y; Chen X; Wang L; Wang T; Tang X; Su X J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594 [TBL] [Abstract][Full Text] [Related]
4. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
5. High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients. Zhou C; Weng J; Liu C; Zhou Q; Chen W; Hsu JL; Sun J; Atyah M; Xu Y; Shi Y; Shen Y; Dong Q; Hung MC; Ren N Am J Cancer Res; 2020; 10(9):2768-2784. PubMed ID: 33042616 [TBL] [Abstract][Full Text] [Related]
6. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma. Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575 [TBL] [Abstract][Full Text] [Related]
7. WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma. Liang L; Xu H; Dong Q; Qiu L; Lu L; Yang Q; Zhao W; Li Y Front Oncol; 2022; 12():852000. PubMed ID: 35480109 [TBL] [Abstract][Full Text] [Related]
8. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
9. [Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein]. Wang XJ; Shen RF; Wang X; Wang YR; Xiao T Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):396-402. PubMed ID: 32482029 [No Abstract] [Full Text] [Related]
10. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598 [TBL] [Abstract][Full Text] [Related]
11. The miR-561-5p/CX Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway. Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259 [TBL] [Abstract][Full Text] [Related]
13. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
14. Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC). Shen H; Wang Z; Ren S; Wang W; Duan L; Zhu D; Zhang C; Duan Y Int Immunopharmacol; 2020 Apr; 81():106222. PubMed ID: 32007795 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms. Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591 [TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma. Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084 [TBL] [Abstract][Full Text] [Related]
17. ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. Liu R; Kong W; Jiang Z; Zheng S; Yuan X; Ye L J Oncol; 2021; 2021():1379706. PubMed ID: 34484330 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis. Yu T; Lu S; Xie W Oncol Lett; 2020 Jul; 20(1):165-172. PubMed ID: 32565944 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma. Deng X; Bi Q; Chen S; Chen X; Li S; Zhong Z; Guo W; Li X; Deng Y; Yang Y Front Mol Biosci; 2020; 7():611626. PubMed ID: 33505990 [TBL] [Abstract][Full Text] [Related]
20. Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays. Zhang F; Xue M; Jiang X; Yu H; Qiu Y; Yu J; Yang F; Bao Z Cancer Cell Int; 2021 Mar; 21(1):174. PubMed ID: 33731144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]